Breast cancer screening: Controversy of impact

Breast

Volumn 22, Issue S2, 2013, Pages

  Berry, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biases in screening studies; Breast cancer detection; Modeling population breast cancer mortality; Randomized screening trials; Screening mammography

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; AGE; ARTICLE; BAYES THEOREM; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; HUMAN; MAMMOGRAPHY; MATHEMATICAL MODEL; OVERDIAGNOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SIMULATION;

BIASES IN SCREENING STUDIES; BREAST CANCER DETECTION; MODELING POPULATION BREAST CANCER MORTALITY; RANDOMIZED SCREENING TRIALS; SCREENING MAMMOGRAPHY;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FORECASTING; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SAFETY; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84884728707     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.013     Document Type: Article

References (20)

1. Stein Rob Breast exam guidelines now call for less testing November 17, 2009, http://articles.washingtonpost.com/2009-11-17/news/36877178_1_annual-mammograms-biopsies-and-unneeded-treatment-routine-mammograms.
2. Gotzsche P.C. Mammography screening: truth, lies and controversy 2012, Radcliffe Publishing, London.
3. Berry D.A. The screening mammography paradox: better when found, perhaps better not to find. British Journal of Cancer 2008, 98:1729-1730.
4. U.S.Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2009, 151:716-726.
5. Shapiro S., Venet W., Strax P., Venet L. Periodic screening for breast cancer: the health insurance plan project and its sequelae, 1963-1986 1988, Johns Hopkins University Press, Baltimore.
6. Götzsche P.C., Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 2000, 355:129-134.
7. Roberts M.M., Alexander F.E., Anderson T.J., et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990, 335(8684):241-246.
8. Gordis L., Berry D.A., Chu S.Y., Fajardo L.L., Hoel D.G., Laufman L.R., et al. Breast cancer screening for women ages 40-49. Journal of the National Cancer Institute 1997, 89:1015-1026. (Reprinted in Monograph of the Journal of the National Cancer Institute (1997) 22:vii-xii.).
9. Nyström L., Andersson I., Bjurstam N., Frisell J., Nordenskjöld B., Rutqvist L.E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002, 359(9310):909-919. [published erratum appears in Lancet 2002;360:724].
10. Berry D.A. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. Journal of the National Cancer Institute 1998, 90:1431-1439.
11. Miller A.B., To T., Baines C.J., Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Annals of Internal Medicine 2002, 137(5 Part 1):305-312.
12. Miller A.B., To T., Baines C.J., Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. Journal of the National Cancer Institute 2000, 92:1490-1499.
13. Moss S.M., Cuckle H., Evans A., Johns L., Waller M., Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006, 368:2053-2060.
14. Kopans D.B., Halpern E. Re: Benefits and risks of screening mammography for women in their forties: a statistical appraisal. Journal of the National Cancer Institute 1999, 91(4):382-384.
15. [accessed 02.04.13]. http://cisnet.cancer.gov.
16. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine 2005, 353:1784-1792. for the Cancer Intervention and Surveillance Modeling Network (CISNET).
17. Berry D.A., Inoue L., Shen Y., Venier J., Cohen D., Bondy M., et al. Modeling theimpact of treatment and screening on breast cancer mortality: a Bayesian approach. Journal of the National Cancer Institute. Monographs 2006, 36:30-36.
18. Kalager M., Zelen M., Langmark F., Adami H- O. Effect of screening mammography on breast-cancer mortality in Norway. New England Journal of Medicine 2010, 363:1203-1210.
19. Mandelblatt J.S., Cronin K.A., Bailey S., Berry D.A., de Koning H.J., Draisma G., et al. Effects of mammographic screening under different screening schedules: model estimates of potential benefits and harms. Annals of Internal Medicine 2009, 151:738-747. for the Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET).
20. Welch H.G., Black W.C. Overdiagnosis in cancer. Journal of the National Cancer Institute 2010, 102(9):605-613.